These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38916974)

  • 1. Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study.
    Dudoignon E; Chevret S; Tsague S; Hamane S; Chaouat M; Plaud B; Vicault E; Mebazaa A; Legrand M; Alanio A; Denis B; Dépret F; Dellière S
    Clin Infect Dis; 2024 Sep; 79(3):682-689. PubMed ID: 38916974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and characteristics of invasive fungal infections in critically ill burn patients: A multicenter retrospective study.
    Maurel V; Denis B; Camby M; Jeanne M; Cornesse A; Glavnik B; Alanio A; Rousseau AF; Lefloch R; Lagrange-Xelot M; Textoris J; Wiramus S; de Tymowski C; Legrand M
    Mycoses; 2020 Jun; 63(6):535-542. PubMed ID: 32077536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognostic relevance of invasive fungal disease during veno-arterial ECMO: A retrospective single-center study.
    Poth JM; Schmandt M; Schewe JC; Lehmann F; Kreyer S; Kohistani Z; Bakhtiary F; Hischebeth G; Putensen C; Weller J; Ehrentraut SF
    J Crit Care; 2024 Oct; 83():154831. PubMed ID: 38797056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological characteristics and outcome analysis of 266 patients with inhalation injuries combined with total burn area less than 30% total body surface area].
    Jiang Y; Wang KA; Wang BL; Hu LY; Zhu BH; Wu GS; Sun Y; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2021 Apr; 37(4):340-349. PubMed ID: 33887882
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical features in proven and probable invasive fungal disease in children and adolescents at a pediatric referral center: a 5-year experience.
    Kishimoto K; Kasai M; Kawamura N; Ito Y; Yoshida M; Hasegawa D; Kawasaki K; Kosaka Y
    World J Pediatr; 2019 Jun; 15(3):270-275. PubMed ID: 31011987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Fungal Disease in Critically Ill Patients at High Risk: Usefulness of Lymphocyte Subtyping.
    Zhang J; Cui N; Wang H; Han W; Li Y; Xiao M; Liu D
    J Intensive Care Med; 2020 Sep; 35(9):909-918. PubMed ID: 30231674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Kidney Injury After Burn: A Cohort Study From the Parkland Burn Intensive Care Unit.
    Clark AT; Li X; Kulangara R; Adams-Huet B; Huen SC; Madni TD; Imran JB; Phelan HA; Arnoldo BD; Moe OW; Wolf SE; Neyra JA
    J Burn Care Res; 2019 Jan; 40(1):72-78. PubMed ID: 30189043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
    Shahin J; Allen EJ; Patel K; Muskett H; Harvey SE; Edgeworth J; Kibbler CC; Barnes RA; Biswas S; Soni N; Rowan KM; Harrison DA;
    BMC Infect Dis; 2016 Sep; 16(1):480. PubMed ID: 27612566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.
    Bassetti M; Azoulay E; Kullberg BJ; Ruhnke M; Shoham S; Vazquez J; Giacobbe DR; Calandra T
    Clin Infect Dis; 2021 Mar; 72(Suppl 2):S121-S127. PubMed ID: 33709127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea.
    Yang E; Choi EJ; Park HS; Lee SO; Choi SH; Kim YS; Lee JH; Lee JH; Lee KH; Kim SH
    Medicine (Baltimore); 2021 May; 100(20):e25448. PubMed ID: 34011022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.
    Liu J; Huang H; Li Y; Liu L; Li J; Liu Z; Lu J; Ouyang J; Song Y; Zhou D; Ren H; Ma J; Wang C; Yu L; Zhou J; Wang J; Xiao Y; Huang X; Li J
    Tumour Biol; 2016 Jun; 37(6):7893-900. PubMed ID: 26700667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.
    Saxena S; Gee J; Klieger S; Kajon A; Petersen H; Zaoutis T; Fisher B
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):219-225. PubMed ID: 28992290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of invasive candidiasis in patients with extensive burns.
    Allen DM; Ang BS
    Ann Acad Med Singap; 1992 Sep; 21(5):656-9. PubMed ID: 1292395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients in a dedicated burns intensive care unit (BICU) in a developing country.
    Hashmi M; Kamal R
    Burns; 2013 May; 39(3):493-500. PubMed ID: 22939740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.
    Calle-Miguel L; Garrido-Colino C; Santiago-García B; Moreno Santos MP; Gonzalo Pascual H; Ponce Salas B; Beléndez Bieler C; Navarro Gómez M; Guinea Ortega J; Rincón-López EM
    BMC Infect Dis; 2023 May; 23(1):348. PubMed ID: 37226103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
    Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
    Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections in children with leukemia in a tertiary hospital in Oman: An eight-year review.
    Al Hajri H; Al-Salmi W; Al Hinai K; Al-Housni S; Al-Harrasi A; Al Hashami H; Al-Hatmi AMS
    Curr Med Mycol; 2023 Sep; 9(3):16-22. PubMed ID: 38361957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.